ASM International NV (ASMIY)
OTCMKTS · Delayed Price · Currency is USD
490.80
-23.25 (-4.52%)
Jul 31, 2025, 9:45 AM EDT
Achilles Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 527.13 | 685.73 | 752.07 | 389.11 | 494.71 | 285.4 | Upgrade |
Depreciation & Amortization | 135.75 | 125.95 | 129.4 | 85.74 | 67.01 | 66.72 | Upgrade |
Other Amortization | 91.9 | 69.4 | 46.86 | 36.69 | 26.61 | 25.05 | Upgrade |
Loss (Gain) From Sale of Assets | -7.14 | -7.04 | 0.19 | -0.04 | -4.07 | - | Upgrade |
Asset Writedown & Restructuring Costs | -48.53 | -46.63 | -27.58 | -20.51 | -6.01 | -29.58 | Upgrade |
Loss (Gain) From Sale of Investments | 181.4 | - | -215.39 | 215.39 | - | - | Upgrade |
Loss (Gain) on Equity Investments | -6.74 | -9.64 | -17.54 | -64.77 | -74.38 | -44.81 | Upgrade |
Stock-Based Compensation | 42.78 | 41.58 | 37.31 | 29.88 | 17.24 | 12.79 | Upgrade |
Other Operating Activities | 151.34 | 59.84 | -13.69 | 29.47 | -72.86 | 52.19 | Upgrade |
Change in Accounts Receivable | 52.36 | -110.04 | 89.15 | 6.11 | -154.03 | -93 | Upgrade |
Change in Inventory | 14.14 | -31.96 | -3.54 | -276.91 | -39.15 | 0.5 | Upgrade |
Change in Accounts Payable | 3.36 | 112.06 | -9.31 | 120.32 | 103.09 | -12.7 | Upgrade |
Change in Other Net Operating Assets | 6.81 | 8.41 | -32.04 | -8.98 | 22.49 | 1.81 | Upgrade |
Operating Cash Flow | 1,145 | 897.65 | 735.89 | 541.49 | 380.64 | 264.35 | Upgrade |
Operating Cash Flow Growth | 61.08% | 21.98% | 35.90% | 42.26% | 43.99% | -45.93% | Upgrade |
Capital Expenditures | -174.3 | -167.9 | -154.1 | -101.18 | -72.2 | -95.44 | Upgrade |
Sale of Property, Plant & Equipment | 8.82 | 8.82 | 3.56 | 0.94 | 6.16 | 2.35 | Upgrade |
Cash Acquisitions | - | - | - | -314.3 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -215.94 | -196.84 | -163.61 | -107.29 | -84.65 | -67.36 | Upgrade |
Investment in Securities | -9.12 | -7.72 | -5.64 | -1.97 | - | - | Upgrade |
Other Investing Activities | 17.27 | 13.67 | 30.75 | 48.92 | 36.3 | 16.14 | Upgrade |
Investing Cash Flow | -373.27 | -349.97 | -289.04 | -474.88 | -114.4 | -144.31 | Upgrade |
Long-Term Debt Repaid | - | -14.18 | -12.6 | -10.29 | -7.85 | -7.82 | Upgrade |
Net Debt Issued (Repaid) | -14.48 | -14.18 | -12.6 | -10.29 | -7.85 | -7.82 | Upgrade |
Issuance of Common Stock | - | - | 0.86 | - | 4.63 | 2.77 | Upgrade |
Repurchase of Common Stock | -135.77 | -151.37 | -100.93 | - | -140.14 | -66.72 | Upgrade |
Common Dividends Paid | -147.29 | -135.49 | -123.38 | -121.65 | -96.89 | -98.69 | Upgrade |
Other Financing Activities | -0.1 | - | - | -0.66 | - | - | Upgrade |
Financing Cash Flow | -297.63 | -301.03 | -236.05 | -132.6 | -240.26 | -170.45 | Upgrade |
Foreign Exchange Rate Adjustments | -69.12 | 42.58 | 7.15 | -6.2 | 30.29 | -12.24 | Upgrade |
Net Cash Flow | 404.74 | 289.24 | 217.95 | -72.19 | 56.28 | -62.65 | Upgrade |
Free Cash Flow | 970.26 | 729.76 | 581.78 | 440.3 | 308.44 | 168.91 | Upgrade |
Free Cash Flow Growth | 73.38% | 25.44% | 32.13% | 42.75% | 82.60% | -61.63% | Upgrade |
Free Cash Flow Margin | 29.74% | 24.88% | 22.09% | 18.26% | 17.83% | 12.72% | Upgrade |
Free Cash Flow Per Share | 19.67 | 14.78 | 11.74 | 8.97 | 6.31 | 3.42 | Upgrade |
Cash Income Tax Paid | 122.26 | 97.56 | 118.77 | 90.48 | 151.62 | 8.06 | Upgrade |
Levered Free Cash Flow | 738.88 | 511.44 | 336.95 | 178.33 | 104.63 | 95.41 | Upgrade |
Unlevered Free Cash Flow | 738.88 | 512.62 | 339.41 | 179.28 | 105.89 | 96.66 | Upgrade |
Change in Net Working Capital | -261.95 | -143.44 | -35.6 | 151.28 | 146.32 | 47.85 | Upgrade |
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.